Editorial: Opportunities and challenges of head and neck cancer treatment in the era of immune checkpoint inhibitors
Saved in:
Main Authors: | Zheran Liu, Lei Cai, Xingchen Peng |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-07-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1656915/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A Delayed Presentation of Immune Checkpoint Inhibitor Colitis
by: Alicia Nahhas, et al.
Published: (2025-06-01) -
Radiation theraphy of head and neck cancer /
Published: (1989) -
The Role of Monoclonal Antibodies as Therapeutics in HPV-Related Head and Neck Cancers: An Updated Review
by: Michael Zalin, et al.
Published: (2025-04-01) -
Exosomal biomarkers and immune checkpoint inhibitors: advancements and future prospects
by: Can Lu, et al.
Published: (2025-06-01) -
Resistance to immune checkpoint inhibitors in the treatment of metastatic renal cancer
by: A. A. Izmailov, et al.
Published: (2023-09-01)